DIA
Drug Information Association Logo

Press & Media

The DIA 2015 51st Annual Meeting is the largest global multidisciplinary event for the professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products.

DIA 2015 51st Annual Meeting in Washington, DC, June 14-18 will be a “can’t miss event” for media covering all aspects of the life sciences industries. Approved members of the media receive complimentary registration.

Media Registration Guidelines

  • Media registration is open to editors and reporters working full time for print, broadcast, or Web publications with valid press credentials.

Valid press credentials are required at the time of registration and include:

  • A bylined article published by your employing news outlet within the past six months  
  • A copy of news outlet masthead listing your primary role as an editor or reporter  
  • Copy of official reporter/editor photo credential issued by news outlet or government

Bloggers are considered for media credentialing on a case-by-case basis and must provide three of their most recent blog posts on a biotechnology related subject to be considered for registration.

Freelance journalists may apply for complimentary media registration, but must present the following:

  • A signed letter on company letterhead from your assignment editor confirming your assignment to cover the event
  • A bylined story from the publication you are freelancing for dated within the last six months  

Please note that marketing executives, sales representatives, public relations executives, analysts, consultants, authors, and researchers may not register as media.

DIA reserves the right to deny media registration to any individual who does not meet the above guidelines, or to limit the amount of media registrants from any one publication.

DIA reserves the right to request a copy of convention coverage as a requirement for media registration.

To register, please contact

Judy Connors
Judy.Connors@diahome.org | +1.215.293.5860


Annual Meeting Press Releases:

DIA Patient Fellows Illustrate the Power of the Patient in Drug Development

Inspiring Patient Advocates Sit at the Table With Drug Industry Leaders at DIA Meeting

Risk-Based Monitoring in Clinical Trials to Be Explored at DIA Annual Meeting

Worldwide Regulators to Drive Harmonization at DIA Annual Meeting

Experts to Discuss FDA Programs That Encourage Innovation

DIA Annual Meeting to Discuss Patient Perspective to Inform Drug Development and Access

Worldwide Leaders at DIA Annual Meeting to Discuss Hot Topics Facing Industry

Experts to Discuss Relative Effectiveness in Global Drug Development

Innovators in Patient Engagement, Industry and Regulation to Lead DIA 2014 50th Annual Meeting

DIA Executive Program Session to Examine Impact of Industry Shift to Targeted Therapies

DIA 2014 50th Annual Meeting Panel to Explore Clinical Trial Enrollment Obstacles

FDA International Regulators to Discuss Hurdles and Opportunities in Overseas Posts

DIA Annual Meeting Global Regulatory Track to Hold Town Halls

DIA 2014 50th Annual Meeting to Explore Case Studies of Collaboration to Streamline Drug Development

DIA 2014 50th Annual Meeting to Highlight TransCelerate BioPharma Collaboration

Physician Payments Sunshine Act Explored at DIA 2014 50th Annual Meeting

FDA Commissioner Among Top Global Regulators Attending DIA Annual Meeting

Clinical Trial Experts to Discuss Relationship Between “Big Data” and Strategic CRO and Clinical Trial Sponsor Partnerships

Pioneers in Regenerative Therapy to Discuss New Trends in Stem Cell Medicine

Innovative Blue Button Project to Be Discussed at DIA 2014 50th Annual Meeting

DIA 2014 50th Annual Meeting to Explore Regulatory Challenges for Orphan Medicines

DIA 2014 50th Annual Meeting to Examine the Changing Landscape for Bioinnovation

FDA-EMA Leadership to Discuss Pharmacovigilance at DIA Annual Meeting

DIA 2014 50th Annual Meeting to Explore the Impact of 3D Printing on Health Care

DIA 2014 50th Annual Meeting to Highlight New IMI Collaborative Initiative

DIA 2014 50th Annual Meeting to Address Global Debate About Biosimilars

Director of FDA’s Center for Drug Evaluation and Research to Introduce New Office of Pharmaceutical Quality at DIA Annual Meeting

CISCRP Launches Inaugural 5k Run & Walk Event to Recognize all Clinical Trial Volunteers

Leader in Patient Engagement to Give Keynote Address at DIA 2014 50th Annual Meeting

DIA Announces Internationally Acclaimed Leaders as Co-Chairs of Milestone Meeting

FDA-EMA Leadership to Discuss Pharmacovigilance at DIA Annual Meeting